WETHERBY ASSET MANAGEMENT INC – Vertex Pharmaceuticals Incorporated Transaction History
WETHERBY ASSET MANAGEMENT INC portfolio value:
$1.66M
portfolio value
WETHERBY ASSET MANAGEMENT INC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +10.37% | 540 shares | 196K | $289.54 | 5.74K |
| Q2 2022 | share | Decrease | -7.87% | -445 shares | -7K | $281.79 | 5.20K |
| Q1 2022 | share | Increase | +8.13% | 425 shares | 327K | $260.97 | 5.65K |
| Q4 2021 | share | Increase | +28.14% | 1.14K shares | 408K | $222.45 | 5.22K |
| Q3 2021 | share | Decrease | -7.42% | -327 shares | -149K | $181.39 | 4.08K |
| Q2 2021 | share | Decrease | -8.13% | -390 shares | -142K | $201.63 | 4.40K |
| Q1 2021 | share | Decrease | -5.70% | -290 shares | -171K | $214.89 | 4.79K |
| Q4 2020 | share | Decrease | -1.78% | -92 shares | -207K | $236.34 | 5.08K |
| Q3 2020 | share | Decrease | -9.46% | -541 shares | -252K | $272.12 | 5.17K |
| Q2 2020 | share | Increase | +1.15% | 65 shares | 315K | $290.31 | 5.72K |
| Q1 2020 | share | Increase | +8.62% | 449 shares | 206K | $237.95 | 5.65K |
| Q4 2019 | share | Increase | +3.52% | 177 shares | 288K | $218.95 | 5.20K |
| Q3 2019 | share | Increase | +5.45% | 260 shares | -22K | $169.42 | 5.02K |
| Q2 2019 | share | Increase | +1.77% | 83 shares | 12K | $183.38 | 4.76K |
| Q1 2019 | share | Increase | +3.01% | 137 shares | 108K | $183.95 | 4.68K |
| Q4 2018 | share | Increase | +6.98% | 297 shares | -66K | $165.71 | 4.54K |
| Q3 2018 | share | Increase | +5.59% | 225 shares | 136K | $192.74 | 4.25K |
| Q2 2018 | share | Decrease | -1.25% | -51 shares | 19K | $169.96 | 4.02K |
| Q1 2018 | share | Increase | +10.13% | 375 shares | 110K | $162.98 | 4.07K |
| Q4 2017 | share | Increase | +1.70% | 62 shares | 1K | $149.86 | 3.70K |
| Q3 2017 | share | Increase | +7.79% | 263 shares | 119K | $152.04 | 3.64K |
| Q2 2017 | share | Increase | +6.06% | 193 shares | 87K | $128.87 | 3.37K |
| Q1 2017 | share | Increase | 0.00% | 3.18K shares | 348K | $109.35 | 3.18K |
| Q4 2016 | share | Decrease | -100.00% | -3.11K shares | -271K | $73.67 | 0 |
| Q3 2016 | share | Increase | +27.40% | 669 shares | 61K | $87.21 | 3.11K |
| Q2 2016 | share | Decrease | -24.11% | -776 shares | -46K | $86.02 | 2.44K |
| Q1 2016 | share | Decrease | -8.68% | -306 shares | -187K | $79.49 | 3.21K |